3.9 Review

Multidisciplinary Management of Breast Cancer Brain Metastases

Journal

ONCOLOGY-NEW YORK
Volume 30, Issue 10, Pages 923-933

Publisher

UBM MEDICA

Keywords

-

Categories

Funding

  1. Accuray
  2. Angiochem
  3. BBB Therapeutics
  4. Cascadian Therapeutics
  5. Geron Corporation
  6. Lilly
  7. Merck
  8. Merrimack Pharmaceuticals
  9. Novartis
  10. Puma Biotechnology
  11. Sanofi/BiPar Sciences

Ask authors/readers for more resources

This review summarizes the most up-to-date approach to the multidisciplinary management of patients with breast cancer brain metastases. A brief overview of the epidemiology and biology of breast cancer brain metastasis is provided. The perspectives of radiation oncology, neurosurgery, and medical oncology and landmark studies from each discipline are all discussed. We also offer practical tips to help guide the treating physician, including data on antiseizure medications. Finally, we introduce the concept of a multidisciplinary clinic that combines input from medical and radiation oncology, neurosurgery, and support services, which we developed at the University of North Carolina as a coordinated and optimal approach to the management of patients with this complex disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available